Drugs / sodium phosphate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | AMINOSYN 10% (PH6) | — | 1975-12-03 | fda.gov ↗ |
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04730245 | Jun 2018 → Mar 2020 | Parkinson disease | Torre Médica Santé | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07681050 | Jul 2026 → Jul 2028 expected | acute pancreatitis | Duke University | Recruiting | No outcome recorded |
| Phase 2 | NCT01398098 | Oct 2011 → May 2012 | — | Laboratoires Mayoly Spindler | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT01840553 | May 2013 → Mar 2014 | — | Laboratoires Mayoly Spindler | Completed | Met primary |
| Phase 42 trials | ||||||
| Phase 4 | NCT07060222 | Sep 2025 → Nov 2026 expected | — | Hospital Civil de Guadalajara | Recruiting | No outcome recorded |
| Phase 4 | NCT03817788 | Apr 2019 → Apr 2020 | — | Dong Yang | Completed | No outcome recorded |
| Phase not applicable2 trials · 1 missed | ||||||
| — | NCT01823848 | Apr 2013 → Dec 2017 | constipation disorder | Children's Hospital Los Angeles | Terminated | No outcome recorded |
| — | NCT01576965 | Apr 2012 → Aug 2013 | — | University of North Carolina, Chapel Hill | Completed | Missed primary |
| Comparator or background therapy9 trials | ||||||
| Phase 3 | NCT05726097 Comparator | Feb → Oct 2023 | colorectal cancer, inflammatory bowel disease, polyp of colon | Region Skane | Completed | No outcome recorded |
| Phase 3 | NCT00427089 Comparator | Sep 2004 → May 2005 | — | Norgine | Completed | Met primary |
| Phase 4 | NCT01554111 Comparator | Mar 2012 → Sep 2015 | colonic disorder | Queen's University | Completed | No outcome recorded |
| Phase 4 | NCT01427296 Comparator | Sep 2011 → Mar 2014 | — | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00410215 Comparator | Feb 2006 → Jan 2008 | — | Queen's University | Completed | No outcome recorded |
| — | NCT07702799 Comparator | Jul 2026 → Jan 2028 expected | endometrial cancer | Mahmut Yassa | Recruiting | No outcome recorded |
| — | NCT04316858 Comparator | Mar → Aug 2019 | — | Dow University of Health Sciences | Completed | No outcome recorded |
| — | NCT01759706 Comparator | Oct 2010 → Dec 2012 | pancreatic neoplasm | Vita-Salute San Raffaele University | Completed | No outcome recorded |
| — | NCT00558376 Comparator | Jan 2008 → Mar 2009 | — | Sheba Medical Center | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 20 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium phosphate | “Pico-Salax and Sodium phosphate enema” NCT01554111 ↗ |
| Known as | Fleet | “two saline colon enemas with sodium phosphate Fleet®, 2 to 3 hours apart” NCT04730245 ↗ |
| Known as | NaP | “AIM: We herein compare efficacy, acceptability, tolerance and safety of sodium phosphate (NaP) tablets and split-dose PEG for bowel cleansing.” PMID 27864718 ↗ Nov 20162“All patients had a validated indication for colonoscopy and a preparation using sodium phosphate (NaP) tablets.” PMID 25309090 ↗ Oct 2014 “Sodium Phosphate solution (NaP)” NCT00427089 ↗ |
| Route | Oral | “NaP was taken the morning and evening before colonoscopy” PMID 25180609 ↗ Sep 2014 |